DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74 million.

GUIDANCE:

DexCom sees Q4 2022 revenue of $2.88-2.91 billion, versus the consensus of $2.89 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.